Biblio
Export 69 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is J [Clear All Filters]
“Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 60, no. 2, pp. 461-481, 2017.
, “Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 781-99, 2016.
, “The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.”, J Alzheimers Dis, vol. 52, no. 2, pp. 539-59, 2016.
, “The Effect of Exercise on Falls in People Living with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1199-1217, 2023.
, “Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies.”, J Alzheimers Dis, vol. 52, no. 2, pp. 509-17, 2016.
, “Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1141-1179, 2018.
, “Administering Cognitive Tests Through Touch Screen Tablet Devices: Potential Issues.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1169-1182, 2016.
, “Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1115-1130, 2022.
, “Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 62, no. 1, pp. 279-291, 2018.
, “Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.
, “Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?”, J Alzheimers Dis, vol. 57, no. 4, pp. 1017-1039, 2017.
, “Hypoxia-Induced Signaling Activation in Neurodegenerative Diseases: Targets for New Therapeutic Strategies.”, J Alzheimers Dis, vol. 62, no. 1, pp. 15-38, 2018.
, “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
, “A 19-Year-Old Adolescent with Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
, “A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1323-1339, 2018.
, “Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1123-1135, 2017.
, “Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older Adults.”, J Alzheimers Dis, vol. 59, no. 3, pp. 987-996, 2017.
, “Role of the Glyoxalase System in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 887-899, 2018.
, “The Gut Microbiota and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 1-15, 2017.
, “Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 79, no. 2, pp. 531-541, 2021.
, “Crosstalk between Peripheral Small Vessel Properties and Anxious-like Profiles: Sex, Genotype, and Interaction Effects in Mice with Normal Aging and 3×Tg-AD mice at Advanced Stages of Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1531-1538, 2018.
, “Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 919-925, 2017.
, “The Distribution of Urinary Alzheimer-Associated Neuronal Thread Protein and Its Association with Common Chronic Diseases in the General Population.”, J Alzheimers Dis, vol. 65, no. 2, pp. 433-442, 2018.
, “Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.”, Proc Natl Acad Sci U S A, vol. 108, no. 14, pp. 5819-24, 2011.
, “Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ 1-42.”, J Alzheimers Dis, vol. 50, no. 2, pp. 501-16, 2016.
,